Skip to main content
Premium Trial:

Request an Annual Quote

What About the Little Guys?

Spurred on by a discussion in a comment thread on whether NIH is edging out smaller labs because they don't do enough translational work, blogger DrugMonkey takes a look at how many of each type of NIH grant have been awarded each fiscal year. He graphs out RePORTER data at his blog and notes that R15 grants were flat from 2002 to about 2008 and then increased with stimulus funding. In addition CTSA awards increased from 2008 to 2010 while P01 and P50 grants were more variable. "There is no evidence that the mechanism dedicated to funding research at institutions which have $6M or less in research grants in at least 4 of the past 7 fiscal years is being [gotten rid of]," he says.

Mike the Mad Biologist breaks down his thoughts on the matter at his own blog. "I don't think NIH is specifically trying to tank smaller labs. Instead, NIH seems to be reacting to frustration, both within and outside NIH, about the pace (or lack thereof) of translational research," Mike says.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.